Natural polyphenols inhibit different steps of the process of transthyretin (TTR) amyloid fibril formation
about
Functional Amyloid Signaling via the Inflammasome, Necrosome, and Signalosome: New Therapeutic Targets in Heart FailureAmyloid properties of the leader peptide of variant B cystatin C: implications for Alzheimer and macular degenerationEpigallocatechin-3-gallate as a potential therapeutic drug for TTR-related amyloidosis: "in vivo" evidence from FAP mice modelsTetrabromobisphenol A Is an Efficient Stabilizer of the Transthyretin TetramerMolecular Tweezers Targeting Transthyretin AmyloidosisA Caenorhabditis elegans-based assay recognizes immunoglobulin light chains causing heart amyloidosisNovel drugs targeting transthyretin amyloidosis.An overview of drugs currently under investigation for the treatment of transthyretin-related hereditary amyloidosis.Stability of the transthyretin molecule as a key factor in the interaction with a-beta peptide--relevance in Alzheimer's disease.Cooperative stabilization of transthyretin by clusterin and diflunisal.Epigallocatechin-3-gallate rapidly remodels PAP85-120, SEM1(45-107), and SEM2(49-107) seminal amyloid fibrils.Green tea halts progression of cardiac transthyretin amyloidosis: an observational reportTransthyretin (TTR) cardiac amyloidosis.Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity.Protein misfolding and aggregation in cataract disease and prospects for prevention.Inhibition of human transthyretin aggregation by non-steroidal anti-inflammatory compounds: a structural and thermodynamic analysisCurcumin: A multi-target disease-modifying agent for late-stage transthyretin amyloidosis.Natural compounds may open new routes to treatment of amyloid diseasesProtein folding and aggregation into amyloid: the interference by natural phenolic compoundsClearance of extracellular misfolded proteins in systemic amyloidosis: experience with transthyretin.Dietary polyphenol-derived protection against neurotoxic β-amyloid protein: from molecular to clinical.Light chain amyloidosis 2012: a new era.Beneficial properties of natural phenols: highlight on protection against pathological conditions associated with amyloid aggregation.Natural polyphenols binding to amyloid: a broad class of compounds to treat different human amyloid diseases.The transthyretin amyloidoses: advances in therapy.Green tea polyphenols and their potential role in health and disease.Novel strategies for the diagnosis and treatment of cardiac amyloidosis.Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment.Inhibition of amyloid oligomerization into different supramolecular architectures by small molecules: mechanistic insights and design rules.Geroprotectors: A Unified Concept and Screening Approaches.How epigallocatechin gallate can inhibit α-synuclein oligomer toxicity in vitro.Curcumin modulates α-synuclein aggregation and toxicity.Looking for a generic inhibitor of amyloid-like fibril formation among flavone derivatives.The Effect of (-)-Epigallo-catechin-(3)-gallate on Amyloidogenic Proteins Suggests a Common Mechanism.The green tea polyphenol (-)-epigallocatechin gallate prevents the aggregation of tau protein into toxic oligomers at substoichiometric ratios.MMP-14 overexpression correlates with the neurodegenerative process in familial amyloidotic polyneuropathy.Transthyretin chemical chaperoning by flavonoids: Structure-activity insights towards the design of potent amyloidosis inhibitors.Curcumin affords neuroprotection and inhibits α-synuclein aggregation in lipopolysaccharide-induced Parkinson's disease model.Targeting Different Transthyretin Binding Sites with Unusual Natural Compounds.Epigallocatechin-3-gallate remodels apolipoprotein A-I amyloid fibrils into soluble oligomers in the presence of heparin
P2860
Q26776120-BB7146D8-F4B6-44B8-9B68-9D1413378085Q28118595-58CEB114-FD14-44D0-AC4E-193BF4391605Q28478763-1F80A46F-1FB2-434D-99E8-3DA99533B711Q28551432-D225AC86-0A43-4A54-947C-72377926E28FQ29030065-F9EB17C1-3D38-4E4B-BB80-63493DE473E9Q33718805-DF4C1091-5332-49E3-8AEC-A6C70A7F41AAQ34400138-F8536EDC-E4CE-4E2D-B271-BC534E5F34CEQ34428314-23BC7E5C-8715-47AC-8F66-9DE63887E875Q34428889-28F137F8-5C98-4150-8514-EDF62C9BF0A7Q35001154-8DA73D69-9343-4C6E-A33B-8068ADA79ADEQ36090859-F7262425-C299-4C09-A8E9-E758B521FC5BQ36243852-D5C54A35-F521-47D5-8D53-CE1E93FED089Q36408438-80608ECC-482A-4398-B411-FB4FB23E5765Q36615637-233E9ACE-BD45-4BB0-B8A8-F44A7AA35EA0Q36753974-A34BBD7C-25E9-41C8-AC88-88DBFD65F47AQ36790516-599DAD3A-AB82-4622-A303-94373253AA23Q36919063-C511FF14-01E5-4022-90D7-122F7F1E6957Q36983212-929A4021-90B4-4D27-A305-84F89983694DQ37007345-27005165-5DCA-40D0-ACB8-4BCE030A565BQ38028212-14DC73E4-E178-4C23-8B6F-08A25812836AQ38038797-9A53E1B5-3F3F-487C-BC53-54D24F822600Q38072108-91969123-A21B-400B-B914-344E72126110Q38217070-CFEB0939-DF39-4177-8E38-91D29BB8C8E6Q38244247-085F6A0E-E075-4CA5-A3CA-63FA262BCF97Q38517905-87F9B5A8-06AE-4855-B26A-BB122364ED76Q38545255-987B1945-6F7D-4B67-B89E-E758F8D3B0B0Q38614967-5BD8C2D1-14B8-4D06-8524-1CC55777942BQ38663987-976CD100-7129-4FD3-95E7-2BFFFA21A694Q38686092-F03C5C07-FE37-43B4-997A-2CC66CA477B3Q38744592-0F7AD9CB-DD94-43AC-9789-2F5E749A03F8Q38987375-1BC3CEE6-E095-45EE-9B63-558DCDBF4FDBQ39178579-EB365A0A-0840-4C8F-8C93-BDAFED63619AQ40484092-21398E06-3371-488D-B001-45DE4181AACCQ40818380-5321634C-D6B6-4ECF-811A-C51C0A3930A8Q41892980-A15E89EE-2765-4ABF-966D-61056E3D569DQ45913428-74AF4F9D-017A-48E7-94C5-C678DAE46B9BQ46693222-17EAE716-3151-4BC8-B716-E4ECDC549579Q47659411-EFB09D18-E53B-43A1-951D-EA8C0088E296Q50855015-7B86CFFA-C024-4524-B55A-38A5906BCE8FQ56422855-C385BDB0-2B92-4D2D-82C3-9F4AAF6F88D5
P2860
Natural polyphenols inhibit different steps of the process of transthyretin (TTR) amyloid fibril formation
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Natural polyphenols inhibit di ...... (TTR) amyloid fibril formation
@ast
Natural polyphenols inhibit di ...... (TTR) amyloid fibril formation
@en
Natural polyphenols inhibit di ...... (TTR) amyloid fibril formation
@en-gb
Natural polyphenols inhibit di ...... (TTR) amyloid fibril formation
@nl
type
label
Natural polyphenols inhibit di ...... (TTR) amyloid fibril formation
@ast
Natural polyphenols inhibit di ...... (TTR) amyloid fibril formation
@en
Natural polyphenols inhibit di ...... (TTR) amyloid fibril formation
@en-gb
Natural polyphenols inhibit di ...... (TTR) amyloid fibril formation
@nl
prefLabel
Natural polyphenols inhibit di ...... (TTR) amyloid fibril formation
@ast
Natural polyphenols inhibit di ...... (TTR) amyloid fibril formation
@en
Natural polyphenols inhibit di ...... (TTR) amyloid fibril formation
@en-gb
Natural polyphenols inhibit di ...... (TTR) amyloid fibril formation
@nl
P2860
P50
P921
P3181
P1433
P1476
Natural polyphenols inhibit di ...... (TTR) amyloid fibril formation
@en
P2860
P304
P3181
P356
10.1016/J.FEBSLET.2011.06.030
P407
P577
2011-08-04T00:00:00Z